A detailed history of Nantahala Capital Management, LLC transactions in En V Veno Medical Corp stock. As of the latest transaction made, Nantahala Capital Management, LLC holds 477,855 shares of NVNO stock, worth $1.6 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares
477,855
Previous 477,855 -0.0%
Holding current value
$1.6 Million
Previous $2.51 Million -0.0%
% of portfolio
0.17%
Previous 0.17%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$4.62 - $5.5 $82,610 - $98,345
-17,881 Reduced 3.61%
477,855 $2.51 Million
Q1 2024

May 15, 2024

SELL
$3.94 - $6.65 $829,697 - $1.4 Million
-210,583 Reduced 29.81%
495,736 $2.7 Million
Q4 2023

Feb 14, 2024

BUY
$3.46 - $5.73 $2.44 Million - $4.05 Million
706,319 New
706,319 $3.63 Million

Others Institutions Holding NVNO

About enVVeno Medical Corp


  • Ticker NVNO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 9,469,850
  • Market Cap $31.7M
  • Description
  • enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...
More about NVNO
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.